ADAKVEO: payments to doctors
Payments that named ADAKVEO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 2,062
- Transactions
- 4,568
- Average per transaction
- $283
The per-transaction average — $283 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,062 providers the average total is $626, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $1,283,865 | 99.4% |
| Novartis Pharma AG | $7,635 | 0.6% |